Page 1 of 1

Review: Approved treatments since 2018

Posted: Wed Jul 27, 2022 1:22 am
by frodo
Here there is a recent review about the status of MS treatments.

https://link.springer.com/article/10.10 ... 22-00939-9

It deals with:

- Diroximel fumarate
- Siponimod
- Ozanimod
- Ponesimod
- Ocrelizumab
- Ofatumumab

And some information about some others close to approval:

- Ublituximab
- Evobrutinib
- Tolebrutinib
- Remibrutinib
- Fenebrutinib